A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Laskowitz, DT; Kolls, BJ

Published Date

  • June 15, 2010

Published In

Volume / Issue

  • 74 / 24

Start / End Page

  • 2026 -

PubMed ID

  • 20548049

Pubmed Central ID

  • 20548049

Electronic International Standard Serial Number (EISSN)

  • 1526-632X

Digital Object Identifier (DOI)

  • 10.1212/WNL.0b013e3181e03844

Language

  • eng

Conference Location

  • United States